New Risk • Jun 18
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Negative equity (-CA$2.5m). Revenue is less than US$1m. Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Shareholders have been diluted in the past year (23% increase in shares outstanding). Market cap is less than US$100m (CA$27.1m market cap, or US$19.2m). 공시 • Apr 07
ReGen III Corp., Annual General Meeting, May 29, 2026 ReGen III Corp., Annual General Meeting, May 29, 2026. Location: british columbia, vancouver Canada 공시 • Apr 03
ReGen III Corp. announced that it has received CAD 4.037572 million in funding from Embley Park Foundation and other investors On April 1, 2026, ReGen III Corp. closed the oversubscribed transaction. The company issued 3,000,000 units at an issue price of CAD 0.20 for gross proceeds of CAD 600,000 in its third and final tranche. The transaction includes participation from, Brad Kotush for 125,000 units for gross proceeds of CAD 25,000, Embley Park Foundation for 1,125,000 units for gross proceeds of CAD 225,000 and Liam Gallacher for 1,625,000 units for gross proceeds of CAD 325,000. Over the course of closing the three tranches of the offering, the company has issued 20,187,860 units for aggregate gross proceeds of CAD 4,037,572. All securities issued in the final tranche will be subject to a statutory four-month hold period ending August 2, 2026. The company paid finders' fees of CAD 5,000 in cash for final tranche. The company paid total CAD 80,750 as finder's fees related to the offering. The closing of the offering is subject to receipt of al necessary regulatory approvals, including final approval by the TSX Venture Exchange. Insiders of the company purchased 2,875,000 units, representing 14.24% of aggregate units issued in the offering, with the associated common shares representing approximately 1.86% of the issued and outstanding common shares following the closing of the final tranche. The private placement was approved by the board of directors of the company. New Risk • Mar 25
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 15% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-CA$4.6m). Revenue is less than US$1m. Minor Risks Shareholders have been diluted in the past year (15% increase in shares outstanding). Market cap is less than US$100m (CA$28.8m market cap, or US$20.9m). 공시 • Mar 05
ReGen III Corp. announced that it expects to receive CAD 4 million in funding ReGen III Corp. announces a non-brokered private placement to issue 20,000,000 units of the company at a price of CAD 0.20 per unit for gross proceeds of CAD 4,000,000 on March 4, 2026. Each unit will consist of one common share in the capital of the company and one-half of one common share purchase warrant. Each warrant entitles the holder to purchase an additional share at an exercise price of CAD 0.30 per warrant share for a period of three years from the date of issuance. The closing of the offering is subject to receipt of all necessary regulatory approvals, including approval by the TSX Venture Exchange. In connection with the offering, the company may pay certain finders' fees subject to compliance with applicable securities laws and the rules of the exchange. The securities issued pursuant to the offering will be subject to a statutory four-month hold period. New Risk • Jan 14
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 16% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$2.8m free cash flow). Negative equity (-CA$4.6m). Revenue is less than US$1m. Minor Risks Share price has been volatile over the past 3 months (16% average weekly change). Market cap is less than US$100m (CA$21.5m market cap, or US$15.5m). 